Original Article

Clinical characteristics and genotype-phenotype correlation analysis of 43 cases of neonatal hereditary epilepsy

  • HUO Xiangzi ,
  • FENG Lijuan ,
  • MENG Lingzhi ,
  • ZHANG Yudong ,
  • SUN Yuli ,
  • MA Li ,
  • CAO Yanyan ,
  • XIA Yaofang
Expand
  • 1. Clinical Research Center for Children's Health and Disease, Hebei Province; Department of Neonatology, Hebei Children's Hospital; Key Discipline of Medicine, Hebei Province; National Key Clinical Specialty of Neonatology; Shijiazhuang 050031, Hebei, China
    2. Clinical Research Center for Children's Health and Disease, Hebei Province, Genomic Medicine Research Laboratory, Hebei Children's Hospital, Shijiazhuang 050031, Hebei, China

Received date: 2025-09-26

  Accepted date: 2025-12-23

  Online published: 2026-03-06

Abstract

Objective To analyze the clinical and genetic variation characteristics of hereditary epilepsy in neonates and explore the correlation between the characteristics of genetic variations and clinical manifestations. Methods A retrospective collection was made of neonatal hereditary epilepsy cases admitted to Hebei Children's Hospital from January 2019 to December 2024. The cases were divided into KCNQ2 group and non-KCNQ2 group based on the results of gene sequencing. The clinical features of the two groups were compared, and the genotype-phenotype correlation of KCNQ2 was analyzed. Results A total of 43 cases of neonatal hereditary epilepsy were included, including 26 boys and 17 girls, with a gestational age of 39.4 (38.1-40.3) weeks and a birth weight of 3400 (3000-3400) g. There were 24 cases in the KCNQ2 group and 19 cases in the non-KCNQ2 group. The onset time of epilepsy was 3.0 (2.0-7.0) days after birth, which was earlier in the KCNQ2 group than in the non-KCNQ2 group (P<0.05). The main seizure forms were clonic (62.8%) and tonic (53.5%) seizures. The main abnormality on head MRI was abnormal brain parenchymal signal (72.1%). The most common finding on video electroencephalogram was multifocal discharges (34.9%). There were no statistically significant differences between the two groups (P>0.05). In the KCNQ2 group, there were 13 cases of self-limiting neonatal epilepsy (SeLNE) and 11 cases of developmental and epileptic encephalopathy (DEE). Among the 23 cases successfully followed up, 19 cases had seizure control, 8 cases had significant developmental delay, and 2 cases died. In the non-KCNQ2 group, there was 1 case of SeLNE, 10 cases of DEE, and 8 other cases. Among the 13 cases successfully followed up, 7 cases had seizure control, 7 cases had significant developmental delay, and 4 cases died. The proportion of SeLNE in the KCNQ2 group was higher than that in the non-KCNQ2 group (54.2% vs. 5.3%, P<0.01), and the proportion of death and significant developmental delay was lower in the KCNQ2 group (43.5% vs. 84.6%, P=0.033). There were 19 cases of KCNQ2 nucleotide sequence variations, including 10 cases of SeLNE, 5 cases of hereditary variations, and 4 cases of missense variations. Seven amino acid changes were located at the C-terminal. All 9 cases of DEE were de novo variations, including 7 cases of missense variations, and 5 amino acid changes were located at the S4, S6 and adjacent regions, and the B-helix region. Prediction of protein structural changes induced by 11 missense variants: among 4 SeLNE cases, 2 showed alterations in protein secondary structure, 3 exhibited changes in hydrogen bonds, and 4 demonstrated decreased protein stability; among 7 DEE cases, 6 displayed alterations in protein secondary structure, 4 presented changes in hydrogen bonds, and 6 manifested decreased protein stability. Conclusions KCNQ2 gene variations are the most common in neonatal hereditary epilepsy. Compared with other gene variations, KCNQ2-induced neonatal epilepsy has an earlier onset time and a lower proportion of adverse outcomes. Among them, de novo, missense, and variations at important functional domain sites, may be associated with severe phenotypes of DEE.

Cite this article

HUO Xiangzi , FENG Lijuan , MENG Lingzhi , ZHANG Yudong , SUN Yuli , MA Li , CAO Yanyan , XIA Yaofang . Clinical characteristics and genotype-phenotype correlation analysis of 43 cases of neonatal hereditary epilepsy[J]. Journal of Clinical Pediatrics, 2026 , 44(3) : 175 -184 . DOI: 10.12372/jcp.2026.25e1201

References

[1] Pressler RM, Cilio MR, Mizrahi EM, et al. The ILAE classification of seizures and the epilepsies: modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures[J]. Epilepsia, 2021, 62(3): 615-628.
[2] Thomas RH, Berkovic SF. The hidden genetics of epilepsy-a clinically important new paradigm[J]. Nat Rev Neurol, 2014, 10(5): 283-292.
[3] 陈娇阳, 杨莹, 牛雪阳, 等. 新生儿期起病的遗传性癫痫141例致病基因和表型特点[J]. 中华儿科杂志, 2021, 59(9): 767-771.
  Chen JY, Yang Y, Niu XY, et al. Genotypes and clinical features of neonatal-onset genetic epilepsy in 141 patients[J]. Zhonghua Erke Zazhi, 2021, 59(9): 767-771.
[4] 郑侠, 董世霄, 翁景文, 等. 新生儿遗传性癫痫36例临床分析[J]. 中华新生儿科杂志(中英文), 2023, 38(7): 401-406.
  Zheng X, Dong SX, Weng JW, et al. Clinical analysis of 36 cases of neonatal-onset genetic epilepsy[J]. Zhonghua Xinshengerke Zazhi, 2023, 38(7): 401-406.
[5] Wang Y, Liu M, Hua N, et al. Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2-related disorders[J]. Epilepsia, 2025. doi: 10.1111/epi.18653.
[6] Huang Z, Liu B, Xiao T, et al. Neurodevelopmental outcomes prediction in newborns with seizures caused by KCNQ2 gene defects[J]. Neonatology, 2024, 121(2): 178-186.
[7] 黄小娜, 张悦, 冯围围, 等. 儿童心理行为发育问题预警征象筛查表的信度效度评估[J]. 中华儿科杂志, 2017, 55(6): 445-450.
  Huang XN, Zhang Y, Feng WW, et al. Reliability and validity of warning signs checklist for screening psychological, behavioral and developmental problems of children[J]. Zhonghua Erke Zazhi, 2017, 55(6): 445-450.
[8] Zuberi SM, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions[J]. Epilepsia, 2022, 63(6): 1349-1397.
[9] Morrison-Levy N, Borlot F, Jain P, et al. Early-onset developmental and epileptic encephalopathies of infancy: an overview of the genetic basis and clinical features[J]. Pediatric neurology, 2021, 116: 85-94.
[10] 王丽辉, 崔丽平, 杨花芳, 等. 24例KCNQ2基因变异癫痫患儿的临床表型与基因型分析[J]. 临床儿科杂志, 2025, 43(2): 93-98.
  Wang LH, Cui LP, Yang HF, et al. Clinical phenotype and genotype analysis of 24 epileptic children with KCNQ2 gene variation[J]. Linchuang Erke Zazhi, 2025, 43(2): 93-98.
[11] Yu X, Che F, Zhang X, et al. Clinical and genetic analysis of 23 Chinese children with epilepsy associated with KCNQ2 gene mutations[J]. Epilepsia Open, 2024, 9(5): 1658-1669.
[12] 郑思敏, 张永红, 赵冬莹, 等. 新生儿惊厥33例临床特征及高通量测序检测分析[J]. 中华新生儿科杂志, 2020, 35(3): 202-206.
  Zheng SM, Zhang YH, Zhao DY, et al. Clinical characteristics and next-generation sequencing analysis of 33 cases of neonatal seizures[J]. Zhonghua Xinshengerke Zazhi, 2020, 35(3): 202-206.
[13] Kim HJ, Yang D, Kim SH, et al. Clinical characteristics of KCNQ2 encephalopathy[J]. Brain Dev, 2021, 43(2): 244-250.
[14] Kuersten M, Tacke M, Gerstl L, et al. Antiepileptic therapy approaches in KCNQ2 related epilepsy: a systematic review[J]. Eur J Med Genet, 2020, 63(1): 103628.
[15] Falsaperla R, Criscione R, Cimino C, et al. KCNQ2-related epilepsy: genotype-phenotype relationship with tailored antiseizure medication (ASM)-a systematic review[J]. Neuropediatrics, 2023, 54(5): 297-307.
[16] Goto A, Ishii A, Shibata M, et al. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy[J]. Epilepsia, 2019, 60(9): 1870-1880.
[17] Zhang J, Kim EC, Chen C, et al. Identifying mutation hotspots reveals pathogenetic mechanisms of KCNQ2 epileptic encephalopathy[J]. Sci Rep, 2020, 10(1): 4756.
[18] Dirkx N, Miceli F, Taglialatela M, et al. The role of Kv7.2 in neurodevelopment: insights and gaps in our understanding[J]. Front Physiol, 2020, 11: 570588.
[19] 刘睿, 王翠珊, 刘康, 等. 亚分子机制在癫痫基因型-表型相关性研究中的作用研究进展[J]. 中华神经医学杂志, 2025, 24(3): 299-303.
  Liu R, Wang CS, Liu K, et al. Recent advance in role of sub-molecular mechanism in genotype-phenotype association of epilepsy[J]. Zhonghua Shenjing Yixue Zazhi, 2025, 24(3): 299-303.
[20] 王珏, 刘勇乐, 朱慧, 等. KCNQ2突变导致的新生儿期早发癫痫性脑病临床分析[J]. 临床儿科杂志, 2018, 36(9): 662-665.
  Wang J, Liu YL, Zhu H, et al. Clinical analysis of neonatal-onset epileptic encephalopathy caused by KCNQ2 mutation[J]. Linchuang Erke Zazhi, 2018, 36(9): 662-665.
[21] Dahlstrom KM, Salminen TA. Apprehensions and emerging solutions in ML-based protein structure prediction[J]. Curr Opin Struct Biol, 2024, 86: 102819.
[22] Odgis JA, Gallagher KM, Rehman AU, et al. Detection of mosaic variants using genome sequencing in a large pediatric cohort[J]. Am J Med Genet A, 2023, 191(3): 699-710.
[23] Lee IC, Yang JJ, Wong SH, et al. Heteromeric Kv7.2 current changes caused by loss-of-function of KCNQ2 mutations are correlated with long-term neurodevelopmental outcomes[J]. Sci Rep, 2020, 10(1): 13375.
[24] Berecki G, Tao E, Howell K B, et al. Nav1.2 channel mutations preventing fast inactivation lead to SCN2A encephalopathy[J]. Brain, 2025, 148(1): 212-226.
[25] Jiao J, Li L, Sun M, et al. Identification of a novel GRIN2D variant in a neonate with intractable epileptic encephalopathy-a case report[J]. BMC Pediatr, 2021, 21(1): 5.
[26] 柳艳丽, 陈思, 雷一慧, 等. 新生儿D-双功能蛋白缺乏症2例并文献复习[J]. 中华围产医学杂志, 2023, 26(6): 496-501.
  Liu YL, Chen S, Lei YH, et al. Neonatal D-bifunctional protein deficiency: a report of two cases and literature review[J]. Zhonghua Weichan Yixue Zazhi, 2023, 26(6): 496-501.
[27] Yoon S, Penzes P. Roles of ANK2/ankyrin-B in neuro-developmental disorders: isoform functions and implications for autism spectrum disorder and epilepsy[J]. Curr Opin Neurobiol, 2025, 90: 102938.
Outlines

/